Tag: pharmaceuticals
-
Appeals Court Backs Broad Institute in Crispr Case
A U.S. appeals court supported the Broad Institute’s claims it invented a separate Crispr technology from University of California, affirming a previous U.S. patent office ruling.
-
A.I. to Identify Treatment Drivers for Colorectal Cancer
A study will soon get underway with artificial intelligence and simulation analyzing data from clinical trials to identify factors behind responses to a treatment for colorectal cancer.
-
Clinical Trial Underway for Lassa Fever Treatment
An early-stage clinical trial is underway to test a treatment for Lassa fever, a viral disease found in West Africa, infecting as many as 300,000 individuals a year.
-
Nanoscale Sponges Deliver Rheumatoid Arthritis Treatment
An engineering lab developed a technique to load molecules from white blood cells into tiny particles that act like sponges to reduce joint damage in lab mice from rheumatoid arthritis.
-
FDA to Test New Trial Designs, Assess A.I. Models
FDA plans to pilot test new types of complex clinical trials and is considering a procedure to evaluate machine learning algorithms used in diagnostics.
-
Genentech Gains Modular Engineered Antibodies in $5B Deal
A developer of synthetic antibodies that invoke the immune system is partnering with the biopharmaceutical company Genentech to design new therapies for blood-related and solid tumor cancers.
-
A.I., Imaging Shown to Predict Immunotherapy Success
Researchers in France developed a system for computing data from CT scans and genomic analysis to predict the success for therapies that invoke the immune system in patients with solid-tumor cancers.
-
M.D. Anderson, Spin-Off Company Gain $50M from Texas Agency
M.D. Anderson Cancer Center and a spin-off enterprise formed earlier this month are receiving nearly $50 million in grants from Texas’s state cancer prevention and research agency.
-
Biotechs Collaborate on More Precise Gene, Cell Cancer Therapies
Two biotechnology enterprises developing cancer treatments are pooling their efforts to develop therapies aimed at more specific targets across a range of solid tumor types.
-
Trial Testing Cancer Treatment Delivery Compound
A compound designed to help cancer therapies better penetrate and kill solid tumors is being tested in its first clinical trial among patients with pancreatic cancer.